FLGT MEXC RealStocks
Own real FLGT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 22:59:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Fulgent Genetics, Inc. (FLGT) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $24.07, with a market capitalization of $688.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.46 to $31.04. This page covers its latest market performance, valuation, price trends and company information.
$688.98M | |
$24.47 | |
$25.60 | |
$23.91 | |
$24.66 | |
214.57K | |
326.40K | |
-- | |
$31.04 | |
$13.46 | |
-- | |
-- |
Fulgent Genetics, Inc. (FLGT) is trading at $24.07 in after-hours trading as of 2026-11-16 21:16:00, unchanged from the regular-session close of $24.07.
After-hours trading shows how investors are pricing FLGT after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.
Over the past seven days, Fulgent Genetics, Inc. (FLGT) moved from $18.66 to $24.07, representing a gain of 28.97% ($5.41).
The stock traded between $18.44 and $27.41 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 588.73 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 60.3%
FLGT is currently trading at $24.07, placing it 60.3% of the way from its 52-week low of $13.46 to its 52-week high of $31.04. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1,315 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Fulgent Genetics, Inc. (FLGT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to FLGT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between FLGT shares and USD.
FLGT Shares to USD
1.00 FLGT shares = 24.065 USD
Calculations are estimates based on the latest available price and are for reference only.